KRNY (Kearny Financial Corporation) Stock Analysis - SEC Filings

Kearny Financial Corporation (KRNY) is a publicly traded Financial Services sector company. As of May 21, 2026, KRNY trades at $8.23 with a market cap of $502.83M and a P/E ratio of 14.39. KRNY moved +2.75% today. Year to date, KRNY is +10.17%; over the trailing twelve months it is +31.26%. Its 52-week range spans $5.45 to $8.59. Analyst consensus is buy with an average price target of $9.00. Rallies surfaces KRNY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find KRNY SEC filings?

Rallies organizes KRNY SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

KRNY Key Metrics

Key financial metrics for KRNY
MetricValue
Price$8.23
Market Cap$502.83M
P/E Ratio14.39
EPS$0.57
Dividend Yield0.11%
52-Week High$8.59
52-Week Low$5.45
Volume722
Avg Volume0
Revenue (TTM)$322.73M
Net Income$35.86M
Gross Margin0.00%

Latest KRNY News

Recent KRNY Insider Trades

  • Swansson Timothy A sold 900 (~$6.83K) on Mar 10, 2026.
  • Swansson Timothy A sold 600 (~$4.56K) on Mar 10, 2026.
  • Swansson Timothy A sold 2.00K (~$15.20K) on Mar 10, 2026.

KRNY Analyst Consensus

2 analysts cover KRNY: 0 strong buy, 1 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $9.00.

Common questions about KRNY

Where can I find KRNY SEC filings?
Rallies organizes KRNY SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show KRNY 10-K and 10-Q filings?
Rallies organizes KRNY SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is KRNY research on Rallies investment advice?
No. Rallies provides research, data, and educational context for KRNY. It does not provide personalized investment advice.
KRNY

KRNY